Eslicarbazepine acetate is an anticonvulsant medication approved for use in Europe and the United States as monotherapy or as additional therapy for partial-onset seizures epilepsy.
This report contains market size and forecasts of Eslicarbazepine Acetate API in global, including the following market information:
Global Eslicarbazepine Acetate API Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Eslicarbazepine Acetate API Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Eslicarbazepine Acetate API companies in 2021 (%)
The global Eslicarbazepine Acetate API market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Min Purity Less Than 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Eslicarbazepine Acetate API include Tecoland, Dr. Reddy’s Laboratories, Clearsynth, Jigs chemical, Triveni Interchem, Jubilant Life Sciences, ZCL Chemicals, Lupin and Vasoya Industries, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Eslicarbazepine Acetate API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Eslicarbazepine Acetate API Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Eslicarbazepine Acetate API Market Segment Percentages, by Type, 2021 (%)
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Global Eslicarbazepine Acetate API Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Eslicarbazepine Acetate API Market Segment Percentages, by Application, 2021 (%)
Research
Pharmaceutical
Global Eslicarbazepine Acetate API Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Eslicarbazepine Acetate API Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Eslicarbazepine Acetate API revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Eslicarbazepine Acetate API revenues share in global market, 2021 (%)
Key companies Eslicarbazepine Acetate API sales in global market, 2017-2022 (Estimated), (MT)
Key companies Eslicarbazepine Acetate API sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Tecoland
Dr. Reddy’s Laboratories
Clearsynth
Jigs chemical
Triveni Interchem
Jubilant Life Sciences
ZCL Chemicals
Lupin
Vasoya Industries
Ami Lifesciences
Shangyao Kony (Changzhou) Pharmaceutical